Comments by Brian Shilhavy
Editor, Health Impact News
Readers of Health Impact News are all too familiar with news about corruption inside the U.S. Centers for Disease Control and Prevention (CDC).
The CDC is responsible, for example, for protecting the nation’s health and ensuring that pharmaceutical products like vaccines are safe and effective. Yet, the CDC is also the largest purchaser of vaccines from the pharmaceutical industry, spending billions of dollars of taxpayer funds  every year to purchase these vaccines.
Many top executives and leaders at the CDC also leave the agency to take very lucrative positions with pharmaceutical companies, revealing a revolving door policy between the government and Big Pharma. (See: Former CDC Director that Approved Gardasil Vaccine and Became Head of Merck’s Vaccine Division Named “Woman of the Year” )
A CDC whistleblower that revealed corruption in vaccine autism studies a few years ago still has not been subpoenaed by Congress to testify, and this scandal at the CDC that is seen by some as “Bigger than Watergate ” was the focus of the popular film VAXXED  which was released in 2016.
There was great hope that with the new administration in place at the White House that the President and his staff would clean things up at the CDC.
However, with new allegations of conflicts of interest with the current CDC director, who just resigned, the World Mercury Project Team , led by Robert F. Kennedy Jr., issued a press release this week showing that the nation is still waiting for real reform at the CDC.
CDC Director Resigns, but CDC Conflicts of Interest are Par for the Course
by the World Mercury Project Team 
Media outlets are announcing the abrupt resignation of Brenda Fitzgerald, the physician appointed in July, 2017 to head the Centers for Disease Control and Prevention (CDC).
The resignation follows on the heels of reporting by Politico , which uncovered conflicts of interest pertaining to dubious investment decisions made by Fitzgerald after she became the nation’s top public health official—including the purchase of thousands of dollars of tobacco, pharmaceutical and health care stocks.
Individuals interviewed by Politico describe the trading decisions as “sloppy” and “ridiculous” at best and “legally problematic” at worst.
Most headlines are focusing exclusively on the CDC director’s investments in tobacco companies, which strike observers as hypocritical in light of Fitzgerald’s prioritization of tobacco prevention initiatives  while serving as public health commissioner for the state of Georgia prior to joining CDC.
However, Fitzgerald’s sizeable investments in the pharmaceutical and chemical giants Merck and Bayer, among others, should raise just as many red flags.
Both Merck and Bayer have a pattern of wreaking havoc on human health while striving to bury the evidence.
Merck, for example, manufactures the top-selling but devastating Gardasil vaccine and used statistical gimmicks  and other deceptive tactics to conceal Gardasil’s risks.
Whistleblowers also have accused Merck of falsifying  its mumps vaccine data.
Bayer, too, has a track record of “scandal and marketing fraud ,” having once paid out millions to the U.S. government in a medical fraud settlement  after admitting to overcharging for Bayer’s antibiotic Cipro.
Bayer also settled tens of millions after having persisted in selling contaminated blood products  to hemophiliacs.
At present, Bayer is poised to close a “mega-deal ” to merge with Monsanto, which manufactures the glyphosate-containing herbicide RoundUp—both glyphosate  and RoundUp’s other ingredients  have been shown to be highly toxic.
Although the agency owns 56 patents  applicable to vaccines, it has no problem shredding vaccine safety data  it doesn’t like, while continuing to serve as the nation’s powerful (and ostensibly “independent”) arbiter of vaccine policy.
Julie Gerberding, the doctor who led the CDC from 2002 to 2009 (the time period when the Food and Drug Administration approved Gardasil without proper safety testing), left CDC  to become president of Merck Vaccines and subsequently became Merck’s executive vice president for global strategic communications.
Gerberding has benefited handsomely from her shares of Merck stock .
Thus, Brenda Fitzgerald’s personal financial stake in companies such as Merck and Bayer only illustrates, in microcosm, the CDC’s longstanding willingness to cozy up to Big Pharma and Big Health Care in defiance of ethics rules.
What the United States urgently needs—and taxpayers firmly deserve—is ethical leadership across the board at CDC, provided by individuals who are free from financial conflicts both before and after taking office.
The far-reaching health decisions made by CDC officials need to be driven by solid and truly independent science, not by officials’ pocketbooks.
Read the full article at WorldMercuryProject.org.